SCHEMBL3237274

SCHEMBL3237274

CC(C)(C)/C=C\c1c[c]ccc1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3238140 1.00 CYP2C19 (0.34) CYP2C19
SCHEMBL3238135 1.00 CYP2C19 (0.34) CYP2C19
SCHEMBL9454061 0.78 MAOB (0.36)
SCHEMBL9454057 0.78 MAOB (0.36)
SCHEMBL608768 0.77
SCHEMBL608767 0.77
SCHEMBL5577278 0.77
Water SCHEMBL15415928 0.76 CYP2C19 (0.53) CYP2C19
SCHEMBL2025150 0.74 MAOB (0.46)
SCHEMBL922284 0.74 MAOB (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010019828-A1 GLUCAGON RECEPTOR ANTAGONISTS METABASIS THERAPEUTICS, INC. (US) 2010-02-18 WO claimed
WO-2010019828-A1 GLUCAGON RECEPTOR ANTAGONISTS METABASIS THERAPEUTICS, INC. (US) 2010-02-18 WO disclosed